PR Newswire Clinical TrialsOriginal article
JAAD Publication Shows Improved Performance of DecisionDx®-SCC
Data ReadoutpositiveDecisionDx-SCCPositive
AI Analysis
Summary
DecisionDx-SCC shows improved performance with enhanced negative predictive value of 97.3% for low-risk stratification when integrated with select clinicopathologic factors, published in JAAD.
Outcome Details
DecisionDx-SCC demonstrated 97.3% negative predictive value for Class 1A (low risk) results with enhanced performance from integration of clinicopathologic risk factors
Importance:5/10
Sentiment:
0.70
diagnosticpublicationdermatologyrisk stratificationclinical validation
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on September 9, 2026 8:30 PM